$325 Million Private Placement Secured By Propeling Medical Company

($OCUL) - The Impact on Ocular Therapeutix.

The Impact on Ocular Therapeutix

As an investor it's important to stay updated with major news. Get real-time stock market alerts and research by creating an account here.

This funding is expected to significantly propel the company's research and development endeavors, especially the clinical development of AXPAXLI™ for wet AMD treatment. Wet AMD is a ch…